Cocrystal Pharma Total Current Liabilities 2010-2024 | COCP

Cocrystal Pharma total current liabilities from 2010 to 2024. Total current liabilities can be defined as the sum of all liabilities classified as current for having maturities of less than one year.

Cocrystal Pharma Total Current Liabilities 2010-2024 | COCP

Cocrystal Pharma total current liabilities from 2010 to 2024. Total current liabilities can be defined as the sum of all liabilities classified as current for having maturities of less than one year.
Related Stocks
Company NameMarket
Cap
Amgen (AMGN)$178.8B
Regeneron Pharmaceuticals (REGN)$126.4B
Vertex Pharmaceuticals (VRTX)$124.2B
Gilead Sciences (GILD)$103.4B
Bristol Myers Squibb (BMY)$100.3B
CSL (CSLLY)$97.4B
GSK (GSK)$88.2B
Alnylam Pharmaceuticals (ALNY)$35.2B
Argenex SE (ARGX)$31.2B
BioNTech SE (BNTX)$29.7B
Biogen (BIIB)$28.9B
Moderna (MRNA)$27.7B
Illumina (ILMN)$20.7B
BeiGene (BGNE)$19.2B
Genmab (GMAB)$17.5B
BioMarin Pharmaceutical (BMRN)$13.4B
Vaxcyte (PCVX)$13B
Incyte (INCY)$12.8B
Insmed (INSM)$12.6B
Exact Sciences (EXAS)$12.6B
Sarepta Therapeutics (SRPT)$12B
Bio-Techne Corp (TECH)$11.9B
QIAGEN (QGEN)$10.4B
Legend Biotech (LEGN)$9.3B
Bio-Rad Laboratories (BIO.B)$9.1B
Roivant Sciences (ROIV)$8.9B
Ascendis Pharma (ASND)$8.5B
Intra-Cellular Therapies (ITCI)$7.9B
Exelixis (EXEL)$7.9B
Halozyme Therapeutics (HALO)$7.8B